My Lung Health Coach: a 12-week virtual COPD self-management program integrated with your patient portal.

My Lung Health Coach-A Virtual COPD Self-management Support Program Integrated Into the Electronic Patient Record

This program will try a 12-week virtual one-on-one COPD education and self-management support delivered by a certified respiratory educator plus a companion Epic app for adults with COPD who are current or former smokers.

Quick facts

• Phase: NA
• Study type: Interventional
• Enrollment: 50 (estimated)
• Ages: 40 Years to 100 Years
• Sex: All
• Sponsor: Women's College Hospital (other)
• Drugs / interventions: prednisone
• Locations: 1 site (Toronto, Ontario)
• Trial ID: NCT07027852 on ClinicalTrials.gov

What this trial studies

My Lung Health Coach (MLHC) delivers six one-on-one virtual sessions over 12 weeks with certified respiratory educators covering COPD basics, smoking cessation, inhaler and oxygen use, physical activity, mental wellness, vaccinations, symptom self-management, nutrition, travel, and long-term planning. A companion app integrated into the Epic Care Companion at Women’s College Hospital allows participants to track progress and complete session-specific activities on phones, tablets, or desktops. The program targets adults aged 40 and older with COPD who are current or former smokers and able to use the patient portal. The study will test the feasibility and effectiveness of combining educator-led virtual sessions with an integrated patient-facing app in a single-center implementation.

Who should consider this trial

Good fit: Ideal participants are adults age 40 or older with COPD confirmed by a WCH respirologist, who are current or former smokers, able to provide consent, and able to download and use the Epic Care Companion app.

Not a fit: Patients who had a COPD exacerbation in the prior 4 weeks, have clinician-diagnosed asthma, have significant comorbid or terminal illness, are pregnant, or cannot use the Epic Care Companion app are unlikely to benefit or be eligible.

Why it matters

Potential benefit: If successful, MLHC could help people with COPD better manage symptoms, improve adherence to therapies, and reduce urgent healthcare visits through structured education and remote support.

How similar studies have performed: Prior telehealth and structured COPD self-management programs have shown promising improvements in self-care, exercise capacity, and reduced healthcare use, although outcomes vary by program and setting.

Eligibility criteria

Inclusion Criteria:

1. Must be deemed to have capacity to provide informed consent;
2. Must sign and date the informed consent form;
3. Stated willingness to comply with all study procedures;
4. Be diagnosed with COPD as per a WCH Respirologist
5. Be 40 years or older
6. Be a current or ex-smoker
7. Preferred but not required: have a history of at least 1 COPD exacerbation (requiring prednisone or antibiotic use, or an urgent healthcare visit of any kind) in the previous 12 months

Exclusion Criteria:

1. Experienced a COPD exacerbation in the 4 previous weeks to study enrollment
2. Co-diagnosis of asthma by a WCH Respirologist
3. Significant co-morbidities that could interfere with program participation or terminal illness
4. Unwilling to download and use the Epic Care Companion app and has a unsuitable mobile device to do this
5. Pregnancy

Where this trial is running

Toronto, Ontario

• Womens College Hospital — Toronto, Ontario, Canada (RECRUITING)

Study contacts

• Principal investigator: Andrew Kouri, MD — Womens College Hospital
• Study coordinator: Andrew Kouri, MD

Conditions: Copd, COPD, Telehealth, Telemonitoring, Respiratory